Back to 
Bank Julius Baer & Co. Ltd, Zurich
Bank Julius Baer & Co. Ltd, Zurich
INO
6 quarters
Position history for Bank Julius Baer & Co. Ltd, Zurich's holdings in Inovio Pharmaceuticals, Inc.
No. Bank Julius Baer & Co. Ltd, Zurich exited its INO (Inovio Pharmaceuticals) position in Q2 2021. Its Q1 2021 13F listed 2,500 shares worth $23,000. Bank Julius Baer & Co. Ltd, Zurich already held INO in its Q1 2020 13F, the earliest on record, and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$388,000
Total Shares Change
-52,130
Quarter-by-Quarter History
Other major holders of INO: State Street Corp.